Fundamentals · 2026-09-09S&P 500ANNUAL BASIS

Cooper Companies (The)

COO stock analysis · Health Care · Health Care Supplies

FY 2025-10-31ANNUAL FILINGS
Compare ⇄
These are research estimates based on annual filings. Valuation uses a cash-flow proxy and explicit assumptions; prices are not live. Published valuations use annual periods first filed by the price date, with later restatements retained.
Reference share price · USD
$71.71HISTORICAL SNAPSHOT

As of · fund-implied per-share value

Fund holding value ÷ shares held. Not a live quote; not adjusted for later stock splits.

View SEC fund filing ↗
Estimated issuer market cap
$14B

Price × SEC outstanding shares. Shares measured 2026-06-01. Approximate; share and price dates can differ.

View share-count filing ↗
Reviewed debt balance

Reviewed consolidated balance-sheet debt: current debt 47800000 plus noncurrent debt 2457500000, in USD. Includes current borrowings/current maturities already reported in the current debt line; current borrowings are included once in the capital calculation. Uses debt carrying amounts as presented, including financing leases only where included by the issuer; excludes operating leases and trade/insurance liabilities. This is a book-capital proxy, not fair value or a claim that every other liability is financing debt. Applies only to this reviewed fiscal period. Read the financial statement ↗

Valuation

DCF value

$33.78

Equity cash-flow scenario · SEC outstanding shares at 2026-06-01 · -52.9% versus input cap

How this is calculated ↗
Valuation

Reverse DCF

24.1%

Annual basis · read assumptions below

How this is calculated ↗
Valuation

Relative valuation

-31.3%

52 sector peers · median 25.6×

How this is calculated ↗
Valuation

Historical multiples

42.8×

3 annual observations · snapshot P/E 37.3× · -12.9% versus history

How this is calculated ↗
Valuation

Free cash flow yield

3.1%

Annual basis · read assumptions below

How this is calculated ↗
Quality

ROIC / quality

5.1%

Normalized tax · financing-capital proxy

How this is calculated ↗
Valuation

Value composite

46/100

Annual basis · read assumptions below

How this is calculated ↗
Momentum

12–1 price momentum

Split and corporate-action verification is incomplete for these fund observations. Verified adjusted endpoints are required for 12–1 momentum.

Split and corporate-action verification is incomplete for these fund observations. Verified adjusted endpoints are required for 12–1 momentum.

How this is calculated ↗
Investment

Asset growth

0.6%

Annual basis · read assumptions below

How this is calculated ↗
Investment

Net payout yield

2.0%

Annual basis · read assumptions below

How this is calculated ↗
Quality

Accrual quality

-3.4%

Parent-earnings fallback versus consolidated cash flow · scope limitation

How this is calculated ↗
Momentum

Fundamental momentum

1.6%

Annual basis · read assumptions below

How this is calculated ↗

Follow the cash

ANNUAL · USD

Operating cash flow and reinvestment over time

USD · bar maximum 796.1M2020-10-31: cfo $486,600,000.002020-10-31: capex $310,400,000.0020202021-10-31: cfo $738,600,000.002021-10-31: capex $214,400,000.0020212022-10-31: cfo $692,400,000.002022-10-31: capex $242,000,000.0020222023-10-31: cfo $607,500,000.002023-10-31: capex $392,500,000.0020232024-10-31: cfo $709,300,000.002024-10-31: capex $421,200,000.0020242025-10-31: cfo $796,100,000.002025-10-31: capex $362,400,000.002025
Operating cash flowCapital expenditure

Annual USD. Negative bars use a compressed lower scale. Hover or inspect the financial history table for exact values.

Make the assumptions yours

Personal inputs stay in this browser. Blank fields retain published inputs. Five-year forecast; zero net borrowing. Required return must exceed terminal growth.

How sensitive is the valuation?

DCF per-share sensitivity · includes reviewed preferred and minority-owner claims · rows: required return · columns: growth
Return / Growth3.0%5.0%7.0%
8.0%$42.36$46.22$50.37
10.0%$31.04$33.78$36.71
12.0%$24.49$26.58$28.81

Annual financial history

Open SEC filings ↗
Fiscal year-endRevenueNet incomeOperating cash flowCapital expenditureAssets
2025-10-314.1B374.9M796.1M362.4M12.4B
2024-10-313.9B392.3M709.3M421.2M12.3B
2023-10-313.6B294.2M607.5M392.5M11.7B
2022-10-313.3B385.8M692.4M242M11.5B
2021-10-312.9B2.9B738.6M214.4M9.6B
2020-10-312.4B238.4M486.6M310.4M6.7B
2019-10-312.7B466.7M713.2M292.1M6.3B
2018-10-312.5B139.9M668.9M193.6M6.1B

USD, abbreviated. Restated annual history; not a point-in-time backtest. Missing values appear as dashes.

Trace the inputs

MODEL ANNUAL PERIOD
InputValueSEC tag / sourceFiled
revenue4.1BRevenueFromContractWithCustomerExcludingAssessedTax2025-12-05
netIncome374.9MNetIncomeLoss
Parent-attributable fallback: a verified consolidated total is unavailable in the supported tags. Noncontrolling interests have not been assumed to be zero; this may differ in scope from consolidated cash flow or operating income.
2025-12-05
Parent/common earnings proxy374.9MNetIncomeLoss2025-12-05
cfo796.1MNetCashProvidedByUsedInOperatingActivities2025-12-05
capex362.4MPaymentsToAcquirePropertyPlantAndEquipment2025-12-05
operatingIncome682.9MOperatingIncomeLoss2025-12-05
assets12.4BAssets2025-12-05
equity8.2BStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Explicit consolidated amount, including the portion attributable to noncontrolling interests.
2025-12-05
Parent book equity proxy8.2BStockholdersEquity2025-12-05
debt2.5BReviewed manual correction
Reviewed consolidated balance-sheet debt: current debt 47800000 plus noncurrent debt 2457500000, in USD. Includes current borrowings/current maturities already reported in the current debt line; current borrowings are included once in the capital calculation. Uses debt carrying amounts as presented, including financing leases only where included by the issuer; excludes operating leases and trade/insurance liabilities. This is a book-capital proxy, not fair value or a claim that every other liability is financing debt. Applies only to this reviewed fiscal period.
2025-12-05
shortDebt47.1MShortTermBorrowings2025-12-05
cash110.6MCashAndCashEquivalentsAtCarryingValue2025-12-05
shares200MWeightedAverageNumberOfDilutedSharesOutstanding2025-12-05
dividends0PaymentsOfDividendsCommonStock2025-12-05
buybacks290.1MPaymentsForRepurchaseOfCommonStock2025-12-05
issuance16MReviewed manual correction
Bounded FY2025-10-31 consolidated financing-statement extraction. Proceeds related to share-based compensation awards: 5400000 USD [us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions]; Issuance of common stock for employee stock purchase plan: 10600000 USD [us-gaap:ProceedsFromStockPlans]. All 9 financing lines reconcile exactly to reported financing cash flow -425900000 USD. Cash inflows from common shares, employee plans and option exercises are summed once as displayed on the statement; noncash compensation, withholding payments, preferred and noncontrolling interests are excluded. This review applies only to this issuer and fiscal period. Source limitation: issuance follows the separately reported common cash-inflow lines; it is not an independent verification of every gross equity transaction.
2025-12-05